I have told you several times? 'Nafamostat' will be published in an international academic journal!!

Those who applied for hit the upper limit in just one day! Achieved 31% profit!

Congratulations to everyone who applied for the free trial. ^^

※ For those who missed the “COVID-19 treatment drug,” no worries. We are launching again in a big way.

※ Finally starting. HLB (028300) follow-up stock hits the upper limit on Tuesday. ※

▶▶ Starting with a huge ‘upper limit’ on August 18, related to the international journal on ‘Nafamostat’! ‘ㅇㅇㅇㅇㅇㅇ’ related stocks! ▶ Apply for free trial ◀

The Korean Pasteur Institute’s research paper on the efficacy of the drug ‘Nafamostat,’ being developed as a treatment for the novel coronavirus infection, has been published in the international journal ‘Journal of Virology’!!

Previously, the research team attracted attention by announcing that its efficacy is 600 times higher than Gilead Sciences’ Remdesivir!!

▶▶ Heading straight ‘up’ on Tuesday. Moving fast. Beneficiary stocks related to the ‘Nafamostat’ international journal! Don’t miss out [Apply now for stocks related to ‘Nafamostat’ international journal]

“I applied and bought every day for 3 days, and I was amazed to see upper limit profits every day. It felt like a dream or reality. It’s truly amazing how this could happen. It’s been about 4 months since I paid the membership fee and received VIP service, and already 56 million KRW has accumulated in my account. I’m really grateful for making profits every day. Ah! I’m also actively recommending it to my acquaintances.”

(VIP member Kim Cheol-gi, 56 years old)

Now think of this as the last chance. If you miss this opportunity, you should quit.

Exactly on “August 18” it will explode! Don’t miss out and regret it, buy even with just 100,000 KRW!

▶▶ “August 18 upper limit” offered only until today and then closed. [Receive stocks related to ‘Nafamostat’ international journal!] ▶ Receive stocks ◀

[AI recent upper limit hits]

*20.08.13 HLB (028300) upper limit hit!

*20.08.12 Ilsin Bio (068330) upper limit hit!

*20.08.11 Korea Biogen (318000) upper limit hit!

*20.08.10 CIS (222080) upper limit hit!

*20.08.07 Seoyeon Top Metal (019770) upper limit hit!

*20.08.06 Hyosung ONB (097870) upper limit hit!

*20.08.05 DA Technology (196490) upper limit hit!

*20.08.04 Kainos Med (284620) upper limit hit!

*20.08.03 Access Bio (950130) upper limit hit!

*20.07.31 BioSmart (038460) upper limit hit!

*20.07.30 Simtek (222800) upper limit hit!

*20.07.29 Bitsro Tech (042370) upper limit hit!

*20.07.28 Hanmi Science (008930) upper limit hit!

*20.07.27 LTC (170920) upper limit hit!

*20.07.24 Kyungdong Pharmaceutical (011040) upper limit hit!

*20.07.23 Labgenomics (084650) upper limit hit!

*20.07.22 Ilsin Bio (068330) upper limit hit!

*20.07.21 Hwail Pharmaceutical (061250) upper limit hit!

*20.07.20 Newbotec (060260) upper limit hit!

*20.07.17 Euratech (048430) upper limit hit!

*20.07.16 Dong-A Hwasung (041930) upper limit hit!

▶▶ Only 30 people will be given. “Tuesday upper limit”! ▶ Receive now ◀

※ First-come, first-served 30 people closed! Both early and late rounds are finished. The hero of the last injury time winning goal ※

[Today’s stocks of interest]

#HLB #Celltrion #Wooridul Pharmaceutical #Youngjin Pharmaceutical #Kainos Med

※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.